For research use only. Not for therapeutic Use.
Palmitoylcarnitine chloride is a fatty acid-derived mitochondrial substrate, and selectively decreases cell survival in colorectal and prostate cancer cells by affecting on pro-inflammatory pathways, Ca2+ influx, and DHT-like effects[1].
| Catalog Number | I010249 |
| CAS Number | 6865-14-1 |
| Synonyms | (3-carboxy-2-hexadecanoyloxypropyl)-trimethylazanium;chloride |
| Molecular Formula | C23H46ClNO4 |
| Purity | ≥95% |
| InChI | InChI=1S/C23H45NO4.ClH/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-23(27)28-21(19-22(25)26)20-24(2,3)4;/h21H,5-20H2,1-4H3;1H |
| InChIKey | GAMKNLFIHBMGQT-UHFFFAOYSA-N |
| SMILES | CCCCCCCCCCCCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C.[Cl-] |
| Reference | [1]. Al-Bakheit A, et al. Accumulation of Palmitoylcarnitine and Its Effect on Pro-Inflammatory Pathways and Calcium Influx in Prostate Cancer. Prostate. 2016 Oct;76(14):1326-37. |
